Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.042 EUR
38.52 M EUR
159.16 M EUR
823.51 M
About OrbusNeich Medical Group Holdings Limited
Sector
Industry
CEO
David Chien
Headquarters
Hong Kong
ISIN
KYG6773B1005
FIGI
BBG01GN9DZ79
OrbusNeich Medical Group Holdings Ltd. operates as an investment holding company. The firm through its subsidiaries engages in the manufacturing, trading, sales and marketing of medical devices & instruments used for the treatment of coronary and peripheral vascular diseases. The company was founded on July 22, 2021 and is headquartered in Hong Kong.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of Q8T is 0.422 EUR — it hasn't changed in the past 24 hours. Watch OrbusNeich Medical Group Holdings Limited stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange OrbusNeich Medical Group Holdings Limited stocks are traded under the ticker Q8T.
Q8T stock has fallen by −6.22% compared to the previous week, the month change is a −16.44% fall, over the last year OrbusNeich Medical Group Holdings Limited has showed a 35.26% increase.
We've gathered analysts' opinions on OrbusNeich Medical Group Holdings Limited future price: according to them, Q8T price has a max estimate of 0.74 EUR and a min estimate of 0.70 EUR. Watch Q8T chart and read a more detailed OrbusNeich Medical Group Holdings Limited stock forecast: see what analysts think of OrbusNeich Medical Group Holdings Limited and suggest that you do with its stocks.
Q8T stock is 0.00% volatile and has beta coefficient of 0.62. Track OrbusNeich Medical Group Holdings Limited stock price on the chart and check out the list of the most volatile stocks — is OrbusNeich Medical Group Holdings Limited there?
Yes, you can track OrbusNeich Medical Group Holdings Limited financials in yearly and quarterly reports right on TradingView.
OrbusNeich Medical Group Holdings Limited is going to release the next earnings report on Mar 5, 2026. Keep track of upcoming events with our Earnings Calendar.
Q8T net income for the last half-year is 16.67 M EUR, while the previous report showed 20.22 M EUR of net income which accounts for −17.57% change. Track more OrbusNeich Medical Group Holdings Limited financial stats to get the full picture.
OrbusNeich Medical Group Holdings Limited dividend yield was 2.67% in 2024, and payout ratio reached 26.65%. The year before the numbers were 1.42% and 23.46% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 17, 2025, the company has 1.33 K employees. See our rating of the largest employees — is OrbusNeich Medical Group Holdings Limited on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. OrbusNeich Medical Group Holdings Limited EBITDA is 33.27 M EUR, and current EBITDA margin is 24.18%. See more stats in OrbusNeich Medical Group Holdings Limited financial statements.
Like other stocks, Q8T shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade OrbusNeich Medical Group Holdings Limited stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So OrbusNeich Medical Group Holdings Limited technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating OrbusNeich Medical Group Holdings Limited stock shows the sell signal. See more of OrbusNeich Medical Group Holdings Limited technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.